Media Resources | T2 Biosystems
T2 Biosystems Announces FDA 510(k) Submission to Expand the Pathogen Detection on its FDA-Cleared T2Bacteria Panel to Include Detection of Acinetobacter baumannii
Click to edit Master subtitle style
T2 Biosystems: Pandemic Boost Increases Chance Of Long-Term Success (NASDAQ:TTOO) | Seeking Alpha
FDA Clears T2Bacteria Panel for Sepsis Diagnosis | RT
SEC Filing | T2 Biosystems Inc.
T2Bacteria Panel: What you need to know
Antibiotics | Free Full-Text | T2Bacteria and T2Resistance Assays in Critically Ill Patients with Sepsis or Septic Shock: A Descriptive Experience
SEC Filing | T2 Biosystems Inc.
FDA's Approval of T2 Biosystems T2Bacteria Panel Underlines Importance of Sepsis Diagnosis and Treatment | BioSpace
T2 Biosystems(TTOO)$ SummaryT2 Biosystems is a company that...
A culture-free biphasic approach for sensitive and rapid detection of pathogens in dried whole-blood matrix | PNAS
T2 Biosystems nabs $40M private placement from Canon | Fierce Biotech
SEC Filing | T2 Biosystems Inc.
T2 Biosystems | Lexington MA
T2Bacteria Panel
Direct detection of ESKAPEc pathogens from whole blood with the use of the T2Bacteria Panel allows early antimicrobial stewardship intervention in patients with sepsis
FDA clears T2 Biosystems' panel to detect sepsis bacteria - Medical Device Network
Effective Rapid Diagnosis of Bacterial and Fungal Bloodstream Infections by T2 Magnetic Resonance Technology in the Pediatric Population | Journal of Clinical Microbiology
T2 Biosystems files 510(k) for T2Bacteria Panel - MassDevice
Direct detection of ESKAPEc pathogens from whole blood with the use of the T2Bacteria Panel allows early antimicrobial stewardship intervention in patients with sepsis
T2Bacteria® Panel
T2Bacteria Panel Detects and Identifies Bloodstream Infections - Clinical Advisor
CDC Installs T2Dx Instrument to Monitor C. auris Outbreaks in U.S.
T2 Biosystems Announces Plans to Consolidate and Expand Facilities in Massachusetts | citybiz
T2 Bacteria panel
